Nestle Q3 results preview: PAT, revenue growth seen marginal as muted demand weighs on earnings
Nestle India is expected to see marginal revenue and profit growth in Q3, impacted by muted consumer demand and high ...
finanzen48m
Karolinska Development’s portfolio company Dilafor advances tafoxiparin following successful meetings with FDA and European regulatory authorities
Dilafor has completed interactions with US and European authorities during 2023 – 2024 to achieve an alignment in the regulatory process ahead of the upcoming clinical phase 3 trials with the ...